Clinical trial · Observational
Embryonic Ploidy Status in the Oncofertility Population
NCT03350230CI-TRIAL-00066112completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
looking at aneuploidy rates in embryos from patients who are going to or have undergone treatment for a malignancy with gonadotoxic treatment.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Fertility | — | UNRESOLVED | — |
| Oncology | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- oncofertility patients
- description
- oncofertility patients undering controlled ovarian hyperstimulation and embryo cryopreservation who carry a present or past cancer diagnosis
Primary outcomes (1)
- measure
- embryonic aneuploidy rates
- timeFrame
- 1 month
- description
- to evaluate the incidence of embryonic aneuploidy among oncofertility patients compared to the general infertility population
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 45 Years
Show eligibility criteria text
Inclusion Criteria: 1.Present or past oncologic diagnosis requiring potentially gonadotoxic treatment Exclusion Criteria: 1. Oocyte banking 2. Use of oocyte donation 3. Any contraindications to undergoing in vitro fertilization or gonadotropin stimulation 4. Single gene disorder requiring more detailed embryo genetic analysis
References
Publications (0)
Data not yet available
No reference posted for this study.